Literature DB >> 15051724

Role for mammalian neutral sphingomyelinase 2 in confluence-induced growth arrest of MCF7 cells.

Norma Marchesini1, Walid Osta, Jacek Bielawski, Chiara Luberto, Lina M Obeid, Yusuf A Hannun.   

Abstract

Recently, we reported that neutral sphingomyelinase 2 (nSMase2) functions as a bona fide neutral sphingomyelinase and that overexpression of nSMase2 in MCF7 breast cancer cells caused a decrease in cell growth (Marchesini, N., Luberto, C., and Hannun, Y. A. (2003) J. Biol. Chem. 278, 13775-13783). In this study, the role of endogenous nSMase2 in regulating growth arrest was investigated. The results show that endogenous nSMase2 mRNA was up-regulated approximately 5-fold when MCF7 cells became growth-arrested at confluence, and total neutral SMase activity was increased by 119 +/- 41% with respect to control. Cell cycle analysis showed that up-regulation of endogenous nSMase2 correlated with G(0)/G(1) cell cycle arrest and an increase in total ceramide levels (2.4-fold). Analysis of ceramide species showed that confluence caused selective increases in very long chain ceramide C(24:1) (370 +/- 54%) and C(24:0) (266 +/- 81%) during arrest. The role of endogenous nSMase2 in growth regulation and ceramide metabolism was investigated using short interfering RNA (siRNA)-mediated loss-of-function analysis. Down-regulation of nSMase2 with specific siRNA increased the cell population of cells in S phase of the cell cycle by 59 +/- 14% and selectively reverted the effects of growth arrest on the increase in levels of very long chain ceramides. Mechanistically, confluence arrest also induced hypophosphorylation of the retinoblastoma protein (6-fold) and induction of p21(WAF1) (3-fold). Down-regulation of nSMase2 with siRNA largely prevented the dephosphorylation of the retinoblastoma protein and the induction of p21(WAF1), providing a link between the action of nSMase2 and key regulators of cell cycle progression. Moreover, studies on nSMase2 localization in MCF7 cells showed that nSMase2 distributed throughout the cells in subconfluent, proliferating cultures. In contrast, nSMase2 became nearly exclusively located at the plasma membrane in confluent, contact-inhibited cells. Hence, we demonstrate for the first time that nSMase2 functions as a growth suppressor in MCF7 cells, linking confluence to the G(0)/G(1) cell cycle check point.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15051724     DOI: 10.1074/jbc.M313662200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  68 in total

1.  Neutral sphingomyelinase 2 activity and protein stability are modulated by phosphorylation of five conserved serines.

Authors:  Simone Filosto; Majid Ashfaq; Samuel Chung; William Fry; Tzipora Goldkorn
Journal:  J Biol Chem       Date:  2011-11-10       Impact factor: 5.157

2.  nSMase2 activation and trafficking are modulated by oxidative stress to induce apoptosis.

Authors:  Michal Levy; S Sianna Castillo; Tzipora Goldkorn
Journal:  Biochem Biophys Res Commun       Date:  2006-04-19       Impact factor: 3.575

3.  Novel analogs of D-e-MAPP and B13. Part 2: signature effects on bioactive sphingolipids.

Authors:  Alicja Bielawska; Jacek Bielawski; Zdzislaw M Szulc; Nalini Mayroo; Xiang Liu; AiPing Bai; Saeed Elojeimy; Barbara Rembiesa; Jason Pierce; James S Norris; Yusuf A Hannun
Journal:  Bioorg Med Chem       Date:  2007-08-24       Impact factor: 3.641

4.  A novel mitochondrial sphingomyelinase in zebrafish cells.

Authors:  Takeshi Yabu; Akio Shimuzu; Michiaki Yamashita
Journal:  J Biol Chem       Date:  2009-05-08       Impact factor: 5.157

Review 5.  Evolving concepts in cancer therapy through targeting sphingolipid metabolism.

Authors:  Jean-Philip Truman; Mónica García-Barros; Lina M Obeid; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2013-12-30

6.  Distinct roles for de novo versus hydrolytic pathways of sphingolipid biosynthesis in Saccharomyces cerevisiae.

Authors:  L Ashley Cowart; Yasuo Okamoto; Xinghua Lu; Yusuf A Hannun
Journal:  Biochem J       Date:  2006-02-01       Impact factor: 3.857

7.  Confluence induced threonine41/serine45 phospho-beta-catenin dephosphorylation via ceramide-mediated activation of PP1cgamma.

Authors:  Norma Marchesini; Jeffrey A Jones; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2007-11-08

8.  Platelet protease-activated receptor (PAR)4, but not PAR1, associated with neutral sphingomyelinase responsible for thrombin-stimulated ceramide-NF-κB signaling in human platelets.

Authors:  Wei-Fan Chen; Jie-Jen Lee; Chao-Chien Chang; Kuan-Hong Lin; Shwu-Huey Wang; Joen-Rong Sheu
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

9.  Implications of sphingosine kinase 1 expression level for the cellular sphingolipid rheostat: relevance as a marker for daunorubicin sensitivity of leukemia cells.

Authors:  S Sobue; S Nemoto; M Murakami; H Ito; A Kimura; S Gao; A Furuhata; A Takagi; T Kojima; M Nakamura; Y Ito; M Suzuki; Y Banno; Y Nozawa; T Murate
Journal:  Int J Hematol       Date:  2008-02-20       Impact factor: 2.490

10.  Stress-induced sphingolipid signaling: role of type-2 neutral sphingomyelinase in murine cell apoptosis and proliferation.

Authors:  Raphael Devillard; Sylvain Galvani; Jean-Claude Thiers; Jean-Louis Guenet; Yusuf Hannun; Jacek Bielawski; Anne Nègre-Salvayre; Robert Salvayre; Nathalie Augé
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.